医学
临床终点
外科
消化性
随机对照试验
血管造影
内窥镜检查
意向治疗分析
栓塞
消化性溃疡
作者
James Y. Lau,Rapat Pittayanon,Ka-Tak Wong,Nutcha Pinjaroen,Philip Wai Yan Chiu,Rungsun Rerknimitr,Ingrid L. Holster,Ernst J. Kuipers,Kaichun Wu,Kim WL Au,Francis K.L. Chan,Joseph J.�Y. Sung
出处
期刊:Gut
[BMJ]
日期:2018-05-25
卷期号:68 (5): 796-803
被引量:63
标识
DOI:10.1136/gutjnl-2018-316074
摘要
Objectives In the management of patients with bleeding peptic ulcers, recurrent bleeding is associated with high mortality. We investigated if added angiographic embolisation after endoscopic haemostasis to high-risk ulcers could reduce recurrent bleeding. Design After endoscopic haemostasis to their bleeding gastroduodenal ulcers, we randomised patients with at least one of these criteria (ulcers≥20 mm in size, spurting bleeding, hypotensive shock or haemoglobin<9 g/dL) to receive added angiographic embolisation or standard treatment. Our primary endpoint was recurrent bleeding within 30 days. Results Between January 2010 and July 2014, 241 patients were randomised (added angiographic embolisation n=118, standard treatment n=123); 22 of 118 patients (18.6%) randomised to angiography did not receive embolisation. In an intention-to-treat analysis, 12 (10.2%) in the embolisation and 14 (11.4%) in the standard treatment group reached the primary endpoint (HR 1.14, 95% CI 0.53 to 2.46; p=0.745). The rate of reinterventions (13 vs 17; p=0.510) and deaths (3 vs 5, p=0.519) were similar. In a per-protocol analysis, 6 of 96 (6.2%) rebled after embolisation compared with 14 of 123 (11.4%) in the standard treatment group (HR 1.89, 95% CI 0.73 to 4.92; p=0.192). None of 96 patients died after embolisation compared with 5 (4.1%) deaths in the standard treatment group (p=0.108). In a posthoc analysis, embolisation reduced recurrent bleeding only in patients with ulcers≥15 mm in size (2 (4.5%) vs 12 (23.1%); p=0.027). Conclusions After endoscopic haemostasis, added embolisation does not reduce recurrent bleeding. Trial registration number NCT01142180 .
科研通智能强力驱动
Strongly Powered by AbleSci AI